Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseLife at Premier By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Medical and Regulatory Affairs ISO Guidelines for Medical Device Trials: Ethical Considerations and Informed Consent By Premier Research February 24, 2017 Consulting Sharing Risk? No, Sharing Opportunity By Sean Russell February 22, 2017 Consulting Rare Disease Day 2017: With Research, Possibilities Are Limitless By Aaron Tonkin February 17, 2017 Clinical ResearchPhase 1 - Phase 4 The Top 4 Problems Facing Clinical Research Project Managers (And Their Solutions) By Premier Research February 9, 2017 Clinical ResearchPhase 1 - Phase 4 The Top 7 Considerations to Take When Designing Pediatric Analgesia Trials By Scott Millard February 6, 2017 Patient and Stakeholder Engagement Rare Cancer Research from the Patient’s POV By Premier Research January 20, 2017 Previous 1 …50 51 52 53 54 … 57 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today